Skip to main content
Caplight Logo









Enbiosis

Enbiosis

Private
LondonHealthcare & Life Scienceshttps://enbiosis.com/

Last Round

VC Round

Jan 22, 2024

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Enbiosis is a biotechnology company that provides AI-powered gut health solutions for personalized care and precision nutrition.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI, Vertical SaaS

Business Model

B2B

Customer Profile

Usage-Based SaaS, Data as a Service, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

gut microbiome analysismicrobiome testingpersonalized nutritionmicrobiome companyB2B healthcaremedical AIgut healthprecision nutritionhealthcare SaaSwhole genome sequencinggut techpractitioner toolsnutraceutical formulationIBS treatmenthealthcare APIwhite-label SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Enbiosis Comparables

Compare Enbiosis with similar companies based on industry and business-model similarity.

Enbiosis comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biohm Technologies
78%
Biomesight
77%
Microba Life Sciences Ltd
76%

Enbiosis Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJan 22, 2024
AcceleratorMay 1, 2023
SeedMay 27, 2021

Key People

Founding team and executive leadership

Ömer Özkan

CEO Founder

Founding Team

Pelin Kumcular

CEO Office I Team Coordinating Manager

Executive Team

Enbiosis Investors

Notable investors and investment history

Enbiosis investors
InvestorRounds
QINVEST Portföy Yönetimi A.Ş.VC Round
London & PartnersAccelerator
Pragma Capital PartnersVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 138% MoM, reaching 3.9K.

  • Sep 7, 2025

    Grew 24% QoQ, from 21 to 26 employees.

Enbiosis Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Enbiosis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Enbiosis's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range23
Year Founded2019
Last FundingJan 22, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?